PHIO PHARMACEUTICALS CORP. Additional Paid in Capital, Common Stock
PHIO PHARMACEUTICALS CORP. (PHIO) had Additional Paid in Capital, Common Stock of $11.01 million as of 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Balance Sheet › Equity
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2012-08-14
- 2012-06-30: Additional Paid in Capital, Common Stock $11.01M.
- 2012-03-31: Additional Paid in Capital, Common Stock $4.42M.
- 2011-12-31: Additional Paid in Capital, Common Stock $3.68M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2012-06-30 | $11.01M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $4.42M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.68M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |